Cantel Medical Reports Results For The Third Quarter Ended April 30, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Piper Jaffray Raises Price Target on Cantel Medical (CMN) Following 3Q15
June 10, 2015 8:21 AM EDTPiper Jaffray reiterates an Overweight rating on Cantel Medical (NYSE: CMN), and raised the price target to $60.00 (from $49.00), following 3Q15. CMN reported sales of $141.5M, which was $5.5M above forecast. Earnings were $0.35, 2 cents above estimates.
Analyst Thomas Gunderson commented, "Strong sales growth of 18% was led by the Endoscopy (up 35%) and Water Purification... More
Cantel Medical (CMN) Tops Q3 EPS by 6c
June 9, 2015 8:08 AM EDTCantel Medical (NYSE: CMN) reported Q3 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $120.06 million versus the consensus estimate of $135.95 million.
For earnings history and earnings-related data on Cantel Medical (CMN) click here.
... More